Gene · 1629
Papers1,694
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,694
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated multi-omics analysis of Alzheimer's disease shows molecular signatures associated with disease progression and potential therapeutic targets. | Sci Rep | 2023 | 36879094 | PubTator, text mining | PubMed |
| Diagnosis of an intermediate case of maple syrup urine disease: A case report. | World J Clin Cases | 2023 | 36874425 | PubTator, text mining | PubMed |
| Prognostic implication of cuproptosis related genes associates with immunity in Ewing's sarcoma. | Transl Oncol | 2023 | 36871208 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway. | Cancer Commun (Lond) | 2023 | 36860124 | PubTator, text mining | PubMed |
| MRPS36 provides a structural link in the eukaryotic 2-oxoglutarate dehydrogenase complex. | Open Biol | 2023 | 36854377 | PubTator, text mining | PubMed |
| Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status. | Vaccines (Basel) | 2023 | 36851309 | PubTator, text mining | PubMed |
| Research experimental design for the construction and identification of the pGEX-BCKD-E4A recombinant point-mutant plasmid. | PLoS One | 2023 | 36827343 | PubTator, text mining | PubMed |
| Diverse roles of UBE2T in cancer (Review). | Oncol Rep | 2023 | 36825587 | PubTator, text mining | PubMed |
| Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB. | Front Genet | 2023 | 36816017 | PubTator, text mining | PubMed |
| Novel Cuproptosis-Related Gene Signature for Precise Identification of High-Risk Populations in Low-Grade Gliomas. | Mediators Inflamm | 2023 | 36814682 | PubTator, text mining | PubMed |
| Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer. | Front Genet | 2023 | 36777734 | PubTator, text mining | PubMed |
| Identification and validation of novel lung adenocarcinoma subtypes and construction of prognostic models: based on cuprotosis-related genes. | BMC Pulm Med | 2023 | 36774456 | PubTator, text mining | PubMed |
| Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. | Sci Rep | 2023 | 36774446 | PubTator, text mining | PubMed |
| Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC. | Sci Rep | 2023 | 36774418 | PubTator, text mining | PubMed |
| Identification of a Novel Model for Predicting the Prognosis and Immune Response Based on Genes Related to Cuproptosis and Ferroptosis in Ovarian Cancer. | Cancers (Basel) | 2023 | 36765541 | PubTator, text mining | PubMed |
| Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration. | Front Genet | 2023 | 36755576 | PubTator, text mining | PubMed |
| Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma. | Biol Direct | 2023 | 36750831 | PubTator, text mining | PubMed |
| Construction of a cuproptosis-associated long non-coding RNA risk prediction model for pancreatic adenocarcinoma based on the TCGA database. | Medicine (Baltimore) | 2023 | 36749249 | PubTator, text mining | PubMed |
Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma. | Dis Markers | 2023 | 36741910 | PubTator, text mining | PubMed |
| Neuroimaging findings of inborn errors of metabolism: urea cycle disorders, aminoacidopathies, and organic acidopathies. | Jpn J Radiol | 2023 | 36729192 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1629/papers?page=14